Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04227574
Other study ID # WAM
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 31, 2020
Est. completion date June 30, 2023

Study information

Verified date September 2023
Source The Hong Kong Polytechnic University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a proof-of-concept pilot nested in the RCT titled, 'Zero-time Exercise on Inactive Adults With Insomnia Disorder'. It aims to evaluate the effects of a simple WhatsApp intervention on exercise adherence and on sleep and related outcomes.


Description:

This is the second phase of another study - 'Zero-time Exercise on Inactive Adults With Insomnia Disorder'. In the first phase (baseline to week 8), 136 subjects will be randomly allocated to the ZTEx intervention or the sleep hygiene education (SHE) comparison group. They will receive two 2-hour ZTEx training or SHE lessons and practice ZTEx or follow the sleep hygiene instruction for 24 weeks. The second phase of the study (weeks 9-24)will commence after completion of the assessment of the RCT at week 8. Subjects in the Zero-time Exercise (ZTEx) group will be randomly divided into either an ZTEx with WhatsApp reminder (ZTEx+R) group or an ZTEx without WhatsApp reminder (ZTEx alone) group to evaluate the effects of WhatsApp reminders on exercise adherence and sleep and related outcomes.


Recruitment information / eligibility

Status Completed
Enrollment 68
Est. completion date June 30, 2023
Est. primary completion date June 30, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: 1. Hong Kong residents, 2. ethnic Chinese aged 18-65 years with the ability to communicate in Cantonese or Putonghua, 3. who fulfil the DSM-5 diagnostic criteria for insomnia disorder according to a validated diagnostic tool, the Brief Insomnia Questionnaire (we include primary insomnia because it is more homogenous and less complicated than comorbid insomnia; if ZTEx is found to be effective for primary insomnia, then comorbid insomnia can be targeted in future studies), 4. scored at least 10 points in the Insomnia Severity Index, 5. are ambulant and can independently perform daily activities, 6. are physically inactive, defined as not having participated in at least 150 min of moderate intensity or 75 min of vigorous intensity physical activity a week, or the equivalent combination over the previous 3 months by self-report 7. have a smartphone compatible with WhatsApp, and 8. willing to give informed consent Exclusion Criteria: 1. any current diagnosis fulfilling the DSM-IV criteria of a major depressive disorder, generalized anxiety disorders, post-traumatic stress disorder, panic disorder, substance use disorders, or schizophrenia as screened using the Chinese version of the Structured Clinical Interview for DSM-IV; 2. other sleep disorders, including circadian rhythm disorder, narcolepsy, obstructive sleep apnoea (OSA), and restless leg syndrome (RLS)/periodic leg movement disorder (PLMD) as determined based on cut-off scores (= 7 on narcolepsy; = 8 on circadian rhythm disorder; = 15 on OSA; = 7 on RLS/PLMD) using SLEEP-50. If in doubt, subjects will be referred to our team psychiatrist (KF Chung) for further assessment; 3. any current medical conditions or side-effects of medication that are contributing significantly to the subject's insomnia; 4. taking medications or currently participating in other psychotherapies for insomnia or other psychiatric disorders; 5. impaired cognitive functioning (<22 points in HK-MoCA) or with difficulty in giving consent or understanding instructions; 6. pregnant; 7. shift work; 8. whose physical condition is such that physicians recommend that they refrain from exercising; and 9. fulfilling the criterion for obesity for Asians (body mass index, of 27.5 or above)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Zero Time Exercise training + WhatsApp anti-inertia reminders
Zero Time Exercise encourage people to increase physical exercise by simple movements that can be done any time at any places. We offer a 2-session training course to train the subjects to do zero-time exercise. In addition, WhatsApp anti-inertia reminders will be sent daily by the research assistant to remind and encourage the participants to practice the Zero Time Exercise.
Zero Time Exercise training alone
Zero Time Exercise encourage people to increase physical exercise by simple movements that can be done any time at any places. We offer a 2-session training course to train the subjects to do zero-time exercise.

Locations

Country Name City State
Hong Kong School of Nursing, the Hong Kong Polytechnic University Hong Kong

Sponsors (1)

Lead Sponsor Collaborator
The Hong Kong Polytechnic University

Country where clinical trial is conducted

Hong Kong, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Insomnia Severity Index The subjects rate the severity of insomnia, the distress, and the functional impairment associated with insomnia on a 5-point scale. The score ranges from 0 to 28. The higher the score, the worse the outcome is. week 8, week 16, week 24
Primary Change in the intervention adherence Patients will be told to record their daily physical activities or sleep health hygiene compliance onto the log. week 8, week 16, week 24
Secondary Sleep diary (7-day) The standardized sleep diary records the daily bedtime and rising time, from which the total time in bed (TIB) can be calculated. week 8, week 16, week 24
Secondary Hospital Anxiety and Depression Scale The Hospital Anxiety and Depression Scale is a 14-items self-administered questionnaire, which assesses the severity of depressive and anxiety symptoms. The score ranges from 0-21 for either depression or anxiety. The higher the score, the worse the outcome is. week 8, week 16, week 24
Secondary Multidimensional fatigue inventory-20 Multidimensional fatigue inventory-20 is a 20-items self-report instrument designed to measure severity of fatigue. The score ranges from 20 to 100. The higher the score, the worse the outcome is. week 8, week 16, week 24
Secondary Actigraphy (7-day) Actigraphy measures wrist movements to assess sleep or waking state, is accomplished through an accelerometer in a wrist worn device. week 8, week 16, week 24
Secondary Accelerometer (7-day) Accelerometer measures wrist movements to assess the physical activity levels. week 8, week 16, week 24
Secondary Change in WAIS-IV Digit Span forward test Change in Wechsler Adult Intelligence Scale, 4th edition (WAIS-IV) Digit Span forward test score will be used to measure the attention function. week 8, week 16, week 24
Secondary Change in WAIS-IV Color Trails Test Change in Wechsler Adult Intelligence Scale, 4th edition (WAIS-IV) Color Trails Test score will be used to measure the attention function. week 8, week 16, week 24
Secondary Change in WAIS-IV Stroop color-word Test Change in Wechsler Adult Intelligence Scale, 4th edition (WAIS-IV) Stroop color-word Test score will be used to measure the attention function. week 8, week 16, week 24
Secondary Change in the Hong Kong List Learning Test (HKLLT) Change in HKLLT Test score will be used to measure the memory function. week 8, week 16, week 24
Secondary Change in Digit Span-backward and forward test Change in Digit Span-backward and forward test score will be used to measure the memory function. week 8, week 16, week 24
Secondary Change in the interference index of Color Trails Test Change in the interference index of Color Trails Test score will be used to measure the executive function week 8, week 16, week 24
Secondary Change in the interference index of Stroop color-word Test Change in the interference index of Stroop color-word Test score will be used to measure the executive function week 8, week 16, week 24
Secondary Change in the Wisconsin Card Sorting Test Change in the Wisconsin Card Sorting Test score will be used to measure the executive function week 8, week 16, week 24
See also
  Status Clinical Trial Phase
Completed NCT04227587 - Effects of Zero-Time Exercise (ZTEx) on Inactive Adults With Insomnia Disorder N/A
Terminated NCT03050372 - Study of Low Field Magnetic Stimulation (LFMS) on Measures of Sleep N/A
Active, not recruiting NCT03322774 - Sleep To Reduce Incident Depression Effectively N/A
Completed NCT02988375 - Sleep to Prevent Evolving Affecting Disorders N/A
Recruiting NCT06281756 - Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia Early Phase 1
Completed NCT03155750 - Effects of Zero-Time Exercise (ZTEx) on Inactive Adults With Insomnia N/A
Completed NCT04940975 - Occupation-based Sleep Program for People With Insomnia N/A
Not yet recruiting NCT03014960 - Effects of Leader Sleep Improvement on Leadership N/A
Not yet recruiting NCT04806009 - Evaluating an Online Mindfulness-Based Intervention for Insomnia N/A
Completed NCT04719143 - Effects of Insomnia Treatment on Metabolism in Patients With Depression N/A
Recruiting NCT04953559 - Transcranial Magnetic Stimulation of the Default Mode Network to Improve Sleep N/A
Completed NCT04402021 - Exercise and Insomnia Study: The Effects of 1 Week of Exercise Training on Insomnia Severity N/A
Enrolling by invitation NCT06041581 - SHADES Mechanistic Trial N/A
Active, not recruiting NCT03109210 - Therapist-Directed VS Online Therapy for Insomnia Co-Occuring With Sleep Apnea N/A